Article
Zanamivir-resistant influenza viruses with a novel neuraminidase mutation.
Journal of virology - 1 Oct 2009
Hurt Aeron C, Holien Jessica K, Parker Michael, Kelso Anne, Barr Ian G
Abstract excerpt
The neuraminidase inhibitors zanamivir and oseltamivir are marketed for the treatment and prophylaxis of influenza and have been stockpiled by many countries for use in a pandemic. Although recent surveillance has identified a striking increase in the frequency of oseltamivir-resistant seasonal i...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
